上肢の筋肥大を呈した成人発症calpainopathyの孤発男性例

症例は33歳男性.16歳時に健診で血清CK上昇を指摘され,25歳頃から緩徐進行性の下肢筋力低下が出現した.身体診察では翼状肩甲,腰椎前弯の増強,アキレス腱の拘縮,近位筋優位の四肢筋力低下を認め,Gowers徴候は陽性であった.筋肥大は上腕二頭筋や前腕屈筋群においてみられた.筋生検では筋線維の大小不同,再生・壊死線維を認め,calpain3発現が低下していた.遺伝子解析にてCAPN3遺伝子に既知の二つの遺伝子変異を認めたためcalpainopathy(肢帯型筋ジストロフィー limb girdle muscular dystrophy 2A; LGMD2A)と診断した.上肢の筋肥大は下肢に比べ注...

Full description

Saved in:
Bibliographic Details
Published in臨床神経学 Vol. 59; no. 11; pp. 740 - 745
Main Authors 濱口, 眞衣, 藤田, 裕明, 西野, 一三, 鈴木, 圭輔, 中村, 利生, 平田, 幸一
Format Journal Article
LanguageJapanese
Published 日本神経学会 2019
Subjects
Online AccessGet full text
ISSN0009-918X
1882-0654
DOI10.5692/clinicalneurol.cn-001330

Cover

Abstract 症例は33歳男性.16歳時に健診で血清CK上昇を指摘され,25歳頃から緩徐進行性の下肢筋力低下が出現した.身体診察では翼状肩甲,腰椎前弯の増強,アキレス腱の拘縮,近位筋優位の四肢筋力低下を認め,Gowers徴候は陽性であった.筋肥大は上腕二頭筋や前腕屈筋群においてみられた.筋生検では筋線維の大小不同,再生・壊死線維を認め,calpain3発現が低下していた.遺伝子解析にてCAPN3遺伝子に既知の二つの遺伝子変異を認めたためcalpainopathy(肢帯型筋ジストロフィー limb girdle muscular dystrophy 2A; LGMD2A)と診断した.上肢の筋肥大は下肢に比べ注目されにくいが,それらを念頭に置いた診察が重要である.
AbstractList 症例は33歳男性.16歳時に健診で血清CK上昇を指摘され,25歳頃から緩徐進行性の下肢筋力低下が出現した.身体診察では翼状肩甲,腰椎前弯の増強,アキレス腱の拘縮,近位筋優位の四肢筋力低下を認め,Gowers徴候は陽性であった.筋肥大は上腕二頭筋や前腕屈筋群においてみられた.筋生検では筋線維の大小不同,再生・壊死線維を認め,calpain3発現が低下していた.遺伝子解析にてCAPN3遺伝子に既知の二つの遺伝子変異を認めたためcalpainopathy(肢帯型筋ジストロフィー limb girdle muscular dystrophy 2A; LGMD2A)と診断した.上肢の筋肥大は下肢に比べ注目されにくいが,それらを念頭に置いた診察が重要である.
Author 鈴木, 圭輔
藤田, 裕明
平田, 幸一
西野, 一三
中村, 利生
濱口, 眞衣
Author_xml – sequence: 1
  fullname: 濱口, 眞衣
  organization: 獨協医科大学脳神経内科
– sequence: 1
  fullname: 藤田, 裕明
  organization: 獨協医科大学脳神経内科
– sequence: 1
  fullname: 西野, 一三
  organization: 国立精神・神経医療研究センターメディカルゲノム・センターゲノム診療開発部
– sequence: 1
  fullname: 鈴木, 圭輔
  organization: 獨協医科大学脳神経内科
– sequence: 1
  fullname: 中村, 利生
  organization: リハビリテーション天草病院脳神経内科
– sequence: 1
  fullname: 平田, 幸一
  organization: 獨協医科大学脳神経内科
BookMark eNpVUMtKw0AUHaSCsfYf_IHUmUwS7yyl-CgUulFwN0ymE5sSpyWJi-5sNxa7URGKK0EqXdWt0oU_k_TxGaZUEDfncjj33HM5u6ig21ohtE9w2XGZdSDDQAdShFrdRO2wLLWJMaEUbyGDAFgmdh27gAyMMTMZgcsdVIrjwFtzhwGxDVTNvu5X_be097GcDlf99_l4kvaf5o-DtDdKe6-LwUM2my1fZsvRXZ7TEYFud0TS7OaG-XS8Fp4_F7eT7Hu4h7Z9Ecaq9DuL6OLk-LxyZtbqp9XKUc1sUUoT0yJUNjyhGHG9_DvpgSQNBrbrgu0zKl3p--qQioYlGcaeIwBssHzig6cwBaBFVN_cbcWJuFK8EwXXIupyESWBDBX_3wl3GCdkjVLzTTl_m00R8ZagP9sZe9A
ContentType Journal Article
Copyright 2019 日本神経学会
Copyright_xml – notice: 2019 日本神経学会
DOI 10.5692/clinicalneurol.cn-001330
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1882-0654
EndPage 745
ExternalDocumentID article_clinicalneurol_59_11_59_cn_001330_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
OK1
P2P
RJT
ID FETCH-LOGICAL-j333t-213cdbae916b654cb8c1d9846684f93c6cffe73ad2c900b5a88482f1f8be03883
ISSN 0009-918X
IngestDate Wed Sep 03 06:30:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j333t-213cdbae916b654cb8c1d9846684f93c6cffe73ad2c900b5a88482f1f8be03883
OpenAccessLink https://www.jstage.jst.go.jp/article/clinicalneurol/59/11/59_cn-001330/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_clinicalneurol_59_11_59_cn_001330_article_char_ja
PublicationCentury 2000
PublicationDate 2019-00-00
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – year: 2019
  text: 2019-00-00
PublicationDecade 2010
PublicationTitle 臨床神経学
PublicationTitleAlternate 臨床神経学
PublicationYear 2019
Publisher 日本神経学会
Publisher_xml – name: 日本神経学会
References 2) Feng X, Luo S, Li J, et al. Fatty infiltration evaluation and selective pattern characterization of lower limbs in limb-girdle muscular dystrophy type 2A by muscle magnetic resonance imaging. Muscle Nerve 2018;58:536-541.
4) Wicklund MP, Kissel JT. The limb-girdle muscular dystrophies. Neurol Clin 2014;32:729-749, ix.
1) Khadilkar SV, Patel BA, Lalkaka JA. Making sense of the clinical spectrum of limb girdle muscular dystrophies. Pract Neurol 2018;18:201-210.
5) Gallardo E, Saenz A, Illa I. Limb-girdle muscular dystrophy 2A. Handb Clin Neurol 2011;101:97-110.
19) Witting N, Duno M, Vissing J. Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2. Neuromuscul Disord 2013;23:25-28.
8) Kramerova I, Beckmann JS, Spencer MJ. Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A). Biochim Biophys Acta 2007;1772:128-144.
9) Richard I, Hogrel JY, Stockholm D, et al. Natural history of LGMD2A for delineating outcome measures in clinical trials. Ann Clin Transl Neurol 2016;3:248-265.
7) Groen EJ, Charlton R, Barresi R, et al. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain 2007;130:3237-3249.
17) Nalini A, Govindaraju C, Kalra P, et al. Hoffmann’s syndrome with unusually long duration: report on clinical, laboratory and muscle imaging findings in two cases. Ann Indian Acad Neurol 2014;17:217-221.
18) Walters J. Muscle hypertrophy and pseudohypertrophy. Pract Neurol 2017;17:369-379.
13) Bradley WG, Jones MZ, Mussini JM, et al. Becker-type muscular dystrophy. Muscle Nerve 1978;1:111-132.
11) Varkey B, Varkey L. Muscle hypertrophy in myotonia congenita. J Neurol Neurosurg Psychiatry 2003;74:338.
12) Chapin JE, Kornfeld M, Harris A. Amyloid myopathy: characteristic features of a still underdiagnosed disease. Muscle Nerve 2005;31:266-272.
6) Liewluck T, Milone M. Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve 2018;58:167-177.
16) Windpassinger C, Schoser B, Straub V, et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008;82:88-99.
14) Khadilkar SV, Singh RK, Kulkarni KS, et al. A study of clinical and laboratory features of 14 Indian patients with dysferlinopathy. J Clin Neuromuscul Dis 2004;6:1-8.
21) Cros D, Harnden P, Pellissier JF, et al. Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. J Neurol 1989;236:43-47.
20) Paradas C, Llauger J, Diaz-Manera J, et al. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology 2010;75:316-323.
10) Senanayake HM, Dedigama AD, de Alwis RP, et al. Hoffmann syndrome: a case report. Int Arch Med 2014;7:2.
3) Chae J, Minami N, Jin Y, et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001;11:547-555.
22) Fanin M, Angelini C. Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: the yield and the pitfalls. Muscle Nerve 2015;52:163-173.
15) Gamez J, Armstrong J, Shatunov A, et al. Generalized muscle pseudo-hypertrophy and stiffness associated with the myotilin Ser55Phe mutation: a novel myotilinopathy phenotype? J Neurol Sci 2009;277:167-171.
References_xml – reference: 3) Chae J, Minami N, Jin Y, et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001;11:547-555.
– reference: 6) Liewluck T, Milone M. Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve 2018;58:167-177.
– reference: 14) Khadilkar SV, Singh RK, Kulkarni KS, et al. A study of clinical and laboratory features of 14 Indian patients with dysferlinopathy. J Clin Neuromuscul Dis 2004;6:1-8.
– reference: 8) Kramerova I, Beckmann JS, Spencer MJ. Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A). Biochim Biophys Acta 2007;1772:128-144.
– reference: 10) Senanayake HM, Dedigama AD, de Alwis RP, et al. Hoffmann syndrome: a case report. Int Arch Med 2014;7:2.
– reference: 13) Bradley WG, Jones MZ, Mussini JM, et al. Becker-type muscular dystrophy. Muscle Nerve 1978;1:111-132.
– reference: 4) Wicklund MP, Kissel JT. The limb-girdle muscular dystrophies. Neurol Clin 2014;32:729-749, ix.
– reference: 15) Gamez J, Armstrong J, Shatunov A, et al. Generalized muscle pseudo-hypertrophy and stiffness associated with the myotilin Ser55Phe mutation: a novel myotilinopathy phenotype? J Neurol Sci 2009;277:167-171.
– reference: 2) Feng X, Luo S, Li J, et al. Fatty infiltration evaluation and selective pattern characterization of lower limbs in limb-girdle muscular dystrophy type 2A by muscle magnetic resonance imaging. Muscle Nerve 2018;58:536-541.
– reference: 7) Groen EJ, Charlton R, Barresi R, et al. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A. Brain 2007;130:3237-3249.
– reference: 17) Nalini A, Govindaraju C, Kalra P, et al. Hoffmann’s syndrome with unusually long duration: report on clinical, laboratory and muscle imaging findings in two cases. Ann Indian Acad Neurol 2014;17:217-221.
– reference: 19) Witting N, Duno M, Vissing J. Becker muscular dystrophy with widespread muscle hypertrophy and a non-sense mutation of exon 2. Neuromuscul Disord 2013;23:25-28.
– reference: 9) Richard I, Hogrel JY, Stockholm D, et al. Natural history of LGMD2A for delineating outcome measures in clinical trials. Ann Clin Transl Neurol 2016;3:248-265.
– reference: 11) Varkey B, Varkey L. Muscle hypertrophy in myotonia congenita. J Neurol Neurosurg Psychiatry 2003;74:338.
– reference: 12) Chapin JE, Kornfeld M, Harris A. Amyloid myopathy: characteristic features of a still underdiagnosed disease. Muscle Nerve 2005;31:266-272.
– reference: 16) Windpassinger C, Schoser B, Straub V, et al. An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008;82:88-99.
– reference: 18) Walters J. Muscle hypertrophy and pseudohypertrophy. Pract Neurol 2017;17:369-379.
– reference: 21) Cros D, Harnden P, Pellissier JF, et al. Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. J Neurol 1989;236:43-47.
– reference: 5) Gallardo E, Saenz A, Illa I. Limb-girdle muscular dystrophy 2A. Handb Clin Neurol 2011;101:97-110.
– reference: 22) Fanin M, Angelini C. Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: the yield and the pitfalls. Muscle Nerve 2015;52:163-173.
– reference: 1) Khadilkar SV, Patel BA, Lalkaka JA. Making sense of the clinical spectrum of limb girdle muscular dystrophies. Pract Neurol 2018;18:201-210.
– reference: 20) Paradas C, Llauger J, Diaz-Manera J, et al. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies. Neurology 2010;75:316-323.
SSID ssib000959814
ssib058494234
ssib002821941
ssib000940416
ssib002484599
ssib005879791
ssj0060813
Score 2.1875083
Snippet ...
SourceID jstage
SourceType Publisher
StartPage 740
SubjectTerms calpainopathy
上肢の筋肥大
孤発成人発症
Title 上肢の筋肥大を呈した成人発症calpainopathyの孤発男性例
URI https://www.jstage.jst.go.jp/article/clinicalneurol/59/11/59_cn-001330/_article/-char/ja
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 臨床神経学, 2019, Vol.59(11), pp.740-745
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1Na9RANNQK4kX8xG96cI6pyWQmM3NMtlmqUkFoobeQmd2gi2xL2R70ZHux2IuKUDwJUumpXjwoPfhnttv2Z_jeJNkmoqJFWIbJ5H3NvMm-95KZN45zJzQ009zTrp_lzGXgg7s6U9w1PIcZYwLeFbjBee5hOLvA7i_yxYlTX2qrllYHeto8_-W-kpNoFdpAr7hL9h80OyYKDVAH_UIJGobyr3RMEkZiSWREEigpiShJAvANSZSQRJBohsi4usVJwknESCQsDCWKYovyiZQllhJVpU2SENuVZ1lE-AOCSlUVQaQA7S5nT_pLeKjxsxpjjoyBUwMBqAhL1LMSwGUCwtVdYysoCC2RAmBJiwhyK9uZmBPZqoiPXyciybhNYh_vyDaJApwzlmPLIkoSgVTBMbxE4UvpQAqvgJeIqTiSUyBGUocHEYBFolA6mRTwxbh7VUUdwysct5hZSi3sjYXn9mIGycUgGKu_bKn9mVss2-kSvfWHMbDMgVjUsDwKDIs9RhnsbmFsMLrBzb11a1TmRy-fOr9mW0SR16p0U0SRhfNnC8hDhRl1q221Ninq02nTd9HXL7-ANfOLl7M3baKkXEFwiKXppwVuOoZ8nK2kPQhKTlMhfFxH--BRzadXzGt8ylZcydqnesok46oR8_v1zdRcCiWOEziBg6zA5WeVexWCDzs-HhEHtFieh_2--7teg3fZg1irWqdpXcf58865MuabioqOXXAmetlF58xcuarlknNv_9uro_WPw7XPh7ubR-ufRts7w_W3ozcbw7Wt4dqHg43X-3t7h-_3DrdeNp45QBjtbuONd18PXuzsf9-87Cy0k_nWrFseceL2giAYuNQPTEdnXQjSNEwEo6XxOwpiglCyXAUmNHneFUHWoUZ5nuaZlEzS3M-l7mIep-CKM9lf6nevOlNASnvGaOppyjrSy2godCakDjAlIfeuObPFIKTLRR6b9MSav_7_SN1wzuJzVrzUvOlMDlZWu7fAzR_o23Za_QDKrddb
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E4%B8%8A%E8%82%A2%E3%81%AE%E7%AD%8B%E8%82%A5%E5%A4%A7%E3%82%92%E5%91%88%E3%81%97%E3%81%9F%E6%88%90%E4%BA%BA%E7%99%BA%E7%97%87calpainopathy%E3%81%AE%E5%AD%A4%E7%99%BA%E7%94%B7%E6%80%A7%E4%BE%8B&rft.jtitle=%E8%87%A8%E5%BA%8A%E7%A5%9E%E7%B5%8C%E5%AD%A6&rft.au=%E6%BF%B1%E5%8F%A3%2C+%E7%9C%9E%E8%A1%A3&rft.au=%E8%97%A4%E7%94%B0%2C+%E8%A3%95%E6%98%8E&rft.au=%E8%A5%BF%E9%87%8E%2C+%E4%B8%80%E4%B8%89&rft.au=%E9%88%B4%E6%9C%A8%2C+%E5%9C%AD%E8%BC%94&rft.date=2019&rft.pub=%E6%97%A5%E6%9C%AC%E7%A5%9E%E7%B5%8C%E5%AD%A6%E4%BC%9A&rft.issn=0009-918X&rft.eissn=1882-0654&rft.volume=59&rft.issue=11&rft.spage=740&rft.epage=745&rft_id=info:doi/10.5692%2Fclinicalneurol.cn-001330&rft.externalDocID=article_clinicalneurol_59_11_59_cn_001330_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-918X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-918X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-918X&client=summon